featured
Pilot Study of Pembrolizumab Plus Exemestane/Leuprolide for Premenopausal MBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: